Bryan A. Irving
InvestorSenior Advisor at Frazier Life Sciences
Mountain View, California, United States
About
Bryan A. Irving is a biotech executive and independent consultant with over thirty years of experience in T cell-focused research and more than twenty-three years in industry immunology roles spanning autoimmunity and cancer immunotherapy. He holds a Ph.D. in Immunology from UCSF and a B.A. in Physiology from UC Berkeley, and has held senior research and development positions at Genentech, CytomX Therapeutics, Five Prime Therapeutics, and Amunix Pharmaceuticals, where he contributed to the development of atezolizumab (Tecentriq) and other immunotherapies that advanced to clinical development. Irving currently serves as a Senior Advisor at Frazier Life Sciences and provides consulting services to biotech companies.
Experience
- Independent Biotech ConsultantBiotech Executive and Independent Consultantcurrent2024 — present
- Frazier Life SciencesSenior Advisor for Frazier Life Sciencescurrent2023 — presentMenlo Park, California, United States
- 3T BiosciencesChief Scientific Officer2023 — 2024South San Francisco, California, United States
- Amunix Pharmaceuticals, IncChief Scientific Officer2019 — 2022South San Francisco, California, United States
- Five Prime Therapeutics, Inc.Executive Vice President and Chief Scientific Officer2018 — 2019
- Five Prime Therapeutics, Inc.Senior Vice President, Research2017 — 2018South San Francisco
- CytomX TherapeuticsVice President, Cancer Immunology2015 — 2017
- CytomX TherapeuticsSr. Director of Cancer Immunology2014 — 2015
- CytomX TherapeuticsDirector of Cancer Immunology2013 — 2014
- GenentechScientist - Depts of Oncology & Immunology2001 — 2013
Skills & more
+4 more
Drug DevelopmentBiochemistryINDPharmaceutical IndustryFrom Bryan's professional profile.
Colleagues at Frazier Life Sciences
Frequently asked questions
- Who is Bryan A. Irving?
- Bryan A. Irving is a biotech executive and independent consultant with over thirty years of experience in T cell-focused research and more than twenty-three years in industry immunology roles spanning autoimmunity and cancer immunotherapy. He holds a Ph.D. in Immunology from UCSF and a B.A. in Physiology from UC Berkeley, and has held senior research and development positions at Genentech, CytomX Therapeutics, Five Prime Therapeutics, and Amunix Pharmaceuticals, where he contributed to the development of atezolizumab (Tecentriq) and other immunotherapies that advanced to clinical development. Irving currently serves as a Senior Advisor at Frazier Life Sciences and provides consulting services to biotech companies.
- Where does Bryan A. Irving work?
- Bryan A. Irving is Senior Advisor at Frazier Life Sciences.
- Where did Bryan A. Irving go to school?
- Bryan A. Irving studied at University of CA, San Francisco (Post-doctoral fellowship, T cell biology); University of CA, San Francisco (Ph.D, Microbiology and Immunology); University of CA. Berkeley (BA, Molecular Physiology).
Shared employers
Also worked at 3T Biosciences1
Also worked at CytomX Therapeutics2
Also worked at Genentech101
+ 95 more